title: High sensitivity cardiac troponin assays in the clinical laboratories.
abstract: Immunoassays measuring cardiac troponins I or T have become firmly established as critical tools for diagnosing acute myocardial infarction. While most contemporary assays provide adequate diagnostic performance, the increased sensitivity and precision of the new, high sensitivity assays that have already been introduced into clinical practice, provide the potential to further shorten intervals between blood draws or the time needed to detect the first significant troponin elevation. In addition to the relatively modest benefits at the diagnostic end, the high sensitivity assays and the investigational ultrasensitive cardiac troponin assays offer improvements for predicting major adverse cardiovascular events, development of heart failure or transition to end-stage kidney disease. These novel high sensitivity assays can measure troponin concentrations in 50%-100% of healthy individuals and therefore allow for the distribution of troponin values within a healthy cohort to be measured, patient's baseline troponin levels to be monitored, and clinicians to be alerted of deteriorating cardiorenal conditions. We envisage that the high sensitivity assays will become important tools for predicting each patient's risk of future adverse events and for guiding and monitoring corresponding adjustments of preventative therapeutic interventions.
authors.forename: Petr
authors.initials: P
authors.lastname: Jarolim
mesh_terms: D019963:Clinical Chemistry Tests / Q000379:methods* / Q000592:standards; D006801:Humans; D057230:Limit of Detection; D009206:Myocardium / Q000378:metabolism*; D011379:Prognosis; D014336:Troponin / Q000378:metabolism*
chemical_list: D014336:Troponin